Electrophysiology
accessible to all
Bioserenity was founded in 2014 within the Brain and Spinal Cord Institute (ICM)
at the Pitié-Salpêtrière hospital (AP-HP, Paris).
Useful solutions
​
​
BioSerenity aims to facilitate
and to support the medical teams at each stage of the performance and interpretation of an electrophysiological act thanks to to innovative medical devices and collaborative digital platforms.
​
​
For caregivers
​
​
Taking into account the daily life of caregivers, BioSerenity wishes to improve the care and diagnosis of patients through ergonomic interfaces and connected solutions, in medical environments lacking expertise or isolated.
​ ​
​
In collaboration with the medical community
​
BioSerenity listens closely to its users, in order to co-construct solutions that are tailored to their needs. Our solutions are based on feedback from our medical board and partner establishments.
​ ​
​
Management
Vincent MARCEL
CEO
Samir MEDJEBAR
General manager Services France
Board of Directors
Jean SCHMITT
Managing Partner & President
Jolt Capital
Antoine TRANNOY
General Partner
Jolt Capital
Dan NEWMAN
Operating partner
Jolt Capital
Medical and Scientific Board
Pr. Hervé Vespignani
President of the Medical and Scientific Board
Neurologist
Our mission
Develop connected electrophysiology
in order to fight against medical wandering
Our history
BioSerenity is a vast history of electrophysiology and innovation, but above all of women and men.
Find out more here.
2014
The birth of BioSerenity
Creation at the Brain and Spinal Cord Institute of a connected textile to improve diagnosis and monitor epilepsy.
2016
Closer to patients!
Creation of the first production service and remote interpretation of electroencephalograms at destination hospitals.​ 30 Technicians and 20 neurologists at the neurological care in hospitals directly at the patient's bedside!
2018
BioSerenity goes abrodinternational
Opening of the first offices outside France, in the United States (Atlanta, Boston) and in China.
2020
#AllMobilized
BioSerenity wants to contribute to the national effort to help caregivers during COVID
In response to the government's call, Sérénité Protection Santé launched a mask production plant in Troyes, a "factory in the countryside" dedicated to the production of FFP2 and surgical masks for healthcare professionals, creating nearly 150 jobs and producing millions of FFP2 masks. With BioSerenity, Aube will become a source of masks for healthcare professionals all over France!
Did you say ICECAP®?
Our teams imagine the ICECAP®. The concept ? A single-use EEG headset suitable for all adult patients, which can be fitted in less than 5 minutes with no need for prior EEG training. A real innovation for medical teams needing this examination. This new step clearly demonstrates the brand's commitment to to make daily life easier for caregivers!
2022
Draw me a textile!
Creation of BioSerenity workshops combining the production of innovative textiles for BioSerenity for the general public & support for companies in prototyping, from industrial design to the conception of specific textiles.
2023
Always more innovative!
Designed and produced 100% by BioSerenity, our teams are launching
the second version of the Neuronaute acquisition system:
the NEURONAUTE+. More mobile! Smaller ! More connected!
Thanks to this range, BioSerenity responds to the challenge of medical wandering for electrophysiological care to the patient's home.
The family is growing !
Extension of the ICECAP® range with the arrival of the pediatric version. BioSerenity covers all ages from premature to adult!
Examinations performed with the range NEURONAUTE®
&ICECAP®
Thank you for your confidence ! ​
300 partner establishments & 75,000 tele-interpreted electrophysiology examinations in 2023 (EEG, ECG, PSG)
Our partner medical establishments and healthcare professionals renew their trust in us. Every week, more than 1,000 examinations (EEG, ECG, PSG) are carried out and interpreted by our paramedical and medical teams at the patient's bedside, at home or in our health centers.
JOLT CAPITAL invests 26 M€ in BioSerenity
Confident in the solutions and services developed by BioSerenity to address the problem of misdiagnosis, JOLT capital invests €24 million in BioSerenity.
Our challenges
1.
2.
3.
4.
Improving patient care
with connected solutions that facilitate medical exchanges and accelerate diagnosis.
Provide reliable, simple and accessible tools for practitioners whoever context and patient care.
Understand the needs
of caregivers to ensure helpful solutions adapted to their day-to-day needs​
Connect healthcare professionals within the same GHT*
in order to create a local and territorial network for electrophysiological care.
While complying with safety and regulatory requirements
​
* Territorial hospital group
BioSerenity at the service
of caregivers
Innovation through our teams
Our R&D teams made up of engineers, developers
and researchers are actively working to provide techical solutions and innovative technologies. Meeting medical needs and medical innovations are the heart of our commitments and the design of future solutions.
​ ​
​
For the quality of the diagnosis
On a daily basis, our solutions are used by our 300
establishment partners for the electrophysiological support of their patients.
To date, 1, 000 000 patients have benefited from the quality, the quickness and simplicity of our solutions
​ ​
​
